These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2509030)
21. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism. Neer RM; Tregear GW; Potts JT J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258 [TBL] [Abstract][Full Text] [Related]
22. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH. Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082 [TBL] [Abstract][Full Text] [Related]
23. Pseudohypoparathyroidism showing positive phosphaturic and negative cyclic AMP excretion response to parathyroid hormone. Higashi K; Honda K; Morita M; Umeda T; Shimada T; Kimura K; Shido T; Arita I; Sato T Endocrinol Jpn; 1989 Aug; 36(4):465-9. PubMed ID: 2555146 [TBL] [Abstract][Full Text] [Related]
24. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism. Coulson R; Moses AM J Pharmacol Exp Ther; 1975 Sep; 194(3):603-13. PubMed ID: 169346 [TBL] [Abstract][Full Text] [Related]
25. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism. Mallette LE; Kirkland JL; Gagel RF; Law WM; Heath H J Clin Endocrinol Metab; 1988 Nov; 67(5):964-72. PubMed ID: 2846629 [TBL] [Abstract][Full Text] [Related]
26. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3',5'-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism. Unakami H; Furukawa Y; Sohn HE; Yumita S; Miura R; Hanew K; Yoshinaga K Tohoku J Exp Med; 1982 Oct; 138(2):167-75. PubMed ID: 6294914 [TBL] [Abstract][Full Text] [Related]
27. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843 [TBL] [Abstract][Full Text] [Related]
28. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics. Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430 [TBL] [Abstract][Full Text] [Related]
29. Significance of elevated urinary N-acetyl-beta-D-glucosaminidase activity in chronic cadmium poisoning. Nogawa K; Yamada Y; Kido T; Honda R; Ishizaki M; Tsuritani I; Kobayashi E Sci Total Environ; 1986 Sep; 53(3):173-8. PubMed ID: 3764409 [TBL] [Abstract][Full Text] [Related]
30. Acute response of urinary N-acetyl-beta-D-glucosaminidase to mannitol infusion in the dog. Brouhard BH; Lagrone L; Rowe J Am J Med Sci; 1985 Jul; 290(1):11-4. PubMed ID: 3929604 [TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of N-acetyl-beta-D-glucosaminidase in children with type I diabetes mellitus. Ellis EN; Brouhard BH; Lagrone L; Travis LB Diabetes Care; 1983; 6(3):251-5. PubMed ID: 6347577 [TBL] [Abstract][Full Text] [Related]
32. Differentiation of pseudo- and idiopathic hypoparathyroidism by measuring urinary calcitonin. Morimoto S; Onishi T; Kumahara Y; Avioli L J Clin Endocrinol Metab; 1983 Dec; 57(6):1216-20. PubMed ID: 6630414 [TBL] [Abstract][Full Text] [Related]
33. Reduced renal allograft survival is related to low urinary N-acetyl-beta-D-glucosaminidase excretion during the first posttransplant month. Kotanko P; Margreiter R; Pfaller W Transplantation; 1996 Feb; 61(3):388-92. PubMed ID: 8610347 [TBL] [Abstract][Full Text] [Related]
34. An investigation of the biological activity of parathyroid hormone in pseudohypoparathyroidism: comparison with vitamin D deficiency. Allgrove J; Chayen J; Jayaweera P; O'Riordan JL Clin Endocrinol (Oxf); 1984 May; 20(5):503-14. PubMed ID: 6744632 [TBL] [Abstract][Full Text] [Related]
35. A 6-hour human parathyroid hormone (1-34) infusion protocol: studies in normal and hypoparathyroid subjects. McElduff A; Lissner D; Wilkinson M; Cornish C; Posen S Calcif Tissue Int; 1987 Nov; 41(5):267-73. PubMed ID: 2825934 [TBL] [Abstract][Full Text] [Related]
36. [Parathyroid function and uric acid metabolism]. Yoneda M; Takatsuki K; Tomita A Nihon Naibunpi Gakkai Zasshi; 1983 Nov; 59(11):1738-51. PubMed ID: 6667755 [TBL] [Abstract][Full Text] [Related]
37. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity]. Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453 [TBL] [Abstract][Full Text] [Related]
38. Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism. Breslau NA; Notman DD; Canterbury JM; Moses AM Am J Med; 1980 Jun; 68(6):856-60. PubMed ID: 6247909 [TBL] [Abstract][Full Text] [Related]
39. Human parathyroid hormone (1-34) transiently increases the excretion of lysosomal enzymes into urine and the size of renal lysosomes. Iwata T; Sakai K; Hori M; Uchida S; Towatari T; Kido H J Biochem; 1999 Sep; 126(3):485-93. PubMed ID: 10467163 [TBL] [Abstract][Full Text] [Related]
40. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis. Hultberg B; Ravnskov U Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]